The much higher expression of mucins (MUC1, MUC4, MUC5AC, MUC13 and MUC16) in ovarian tumors compared to the surrounding normal tissues can be exploited for the purpose of radioimmunodiagnosis (RID) and radioimmunotherapy (RIT). This evidence concerns the gene MUC1 and ovarian neoplasm.